Results 221 to 230 of about 37,267 (288)
Daratumumab-based regimens versus CyBorD in newly diagnosed patients with AL amyloidosis and IIIb cardiac stage: A matched case-control study. [PDF]
Bellofiore C+11 more
europepmc +1 more source
Case of Frozen Leads: An Old but Persistent Challenge
ABSTRACT Frozen leads are a rare but clinically relevant complication during cardiac device replacement. A 77‐year‐old man undergoing pacemaker upgrade had atrial and ventricular leads firmly adhered to the generator header despite set screw removal and ethanol application.
Takamasa Ishikawa+9 more
wiley +1 more source
Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis. [PDF]
Morgan GJ+4 more
europepmc +1 more source
Abstract MicroRNAs (miRNAs or miRs) are small, non‐coding RNAs that play a crucial role in gene regulation, making them potential biomarkers for various diseases. In the field of veterinary medicine, there is a growing interest in exploring the diagnostic and therapeutic potential of miRNAs in kidney diseases affecting dogs and cats.
Candice P. Chu, Mary B. Nabity
wiley +1 more source
Spontaneous Hepatic Hemorrhage as a Rare Presentation of Amyloid Light Chain (AL) Amyloidosis: A Case Report. [PDF]
Srivastava M.
europepmc +1 more source
Abstract An approximately 26‐year‐old, suspected female, red‐tailed hawk (Buteo jamaicensis) was presented with a history of chronic ocular changes of the left eye likely secondary to blunt trauma resulting in blindness and phthisis bulbi. Ophthalmic evaluation of OS revealed a large intraocular mass, 3+ aqueous flare indicating anterior uveitis, and ...
Taylr Wells+4 more
wiley +1 more source
Abstract figure legend Schematic illustration of the bidirectional causative link between cerebral amyloid‐beta (Aβ) angiopathy and cardiovascular disease in Alzheimer's disease (AD). Common cardiovascular risk factors like microvascular thrombosis, diabetes, atrial fibrillation, hypertension and atherosclerosis lead to cerebral hypoperfusion and ...
Samuel Parker+2 more
wiley +1 more source
Feasibility of a Biomarker-Based Screening for Pre-Symptomatic AL Amyloidosis in Patients With Intermediate/High-Risk MGUS. [PDF]
Mangiacavalli S+12 more
europepmc +1 more source